文献速递妇科生殖医学

采用下一代测序与实时定量聚合酶链反应识别子宫内膜异位症的候选微小RNA标志物

Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction.
PubMed 文献 · Fertil Steril · 2020-01-01

该回顾性队列研究在大学教学医院纳入腹腔镜确诊的子宫内膜异位症女性与对照组,先用下一代测序筛选差异表达的微小RNA,再用实时定量聚合酶链反应验证。八种微小RNA在病例组显著低于对照组,联合检测的敏感度和特异度分别为0.92和0.86,五种微小RNA组合的敏感度和特异度分别为0.96和0.79。作者认为候选微小RNA组合在区分子宫内膜异位症与对照女性方面与腹腔镜相当。

要点

  • 八种微小RNA(miR-199a-3p、miR-143-3p、miR-340-5p、let-7b-5p、miR-21-5p、miR-17-5p、miR-20a-5p、miR-103a-3p)在病例组显著低于对照组。
  • 八种微小RNA联合检测的敏感度和特异度分别为0.92和0.86,阳性预测值和阴性预测值分别为0.85和0.92。
  • 五种微小RNA(miR-17-5p、miR-20a-5p、miR-199a-3p、miR-143-3p、let-7b-5p)组合的敏感度和特异度分别为0.96和0.79。

核心结论

  • 作者认为候选微小RNA组合在区分子宫内膜异位症女性与对照女性方面与腹腔镜相当。

研究设计与样本

  • 回顾性队列研究,在大学教学医院进行,纳入腹腔镜确诊的子宫内膜异位症女性与对照女性。
  • 采用下一代测序筛选差异表达的微小RNA,并用实时定量聚合酶链反应验证。
  • 另一队列中经手术确诊的子宫内膜异位症女性53例和无病对照女性53例,用分光光度法和实时定量聚合酶链反应检测血浆溶血。
  • 在无溶血血浆样本中,病例组25例和对照组28例用miRcury LNA miRNA进行实时定量聚合酶链反应定量微小RNA特征。

主要发现

  • 八种微小RNA(miR-199a-3p、miR-143-3p、miR-340-5p、let-7b-5p、miR-21-5p、miR-17-5p、miR-20a-5p、miR-103a-3p)在病例组显著低于对照组。
  • 单个微小RNA的敏感度范围为0.36至1.00,特异度范围为0.43至1.00。
  • 八种微小RNA联合检测的敏感度和特异度分别为0.92和0.86,阳性预测值和阴性预测值分别为0.85和0.92。
  • 五种微小RNA(miR-17-5p、miR-20a-5p、miR-199a-3p、miR-143-3p、let-7b-5p)组合的敏感度和特异度分别为0.96和0.79,阳性预测值和阴性预测值分别为0.80和0.96。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify novel candidate diagnostic microRNA (miRNA) markers of endometriosis by means of an unbiased search with confirmation by means of targeted polymerase chain reaction (PCR). DESIGN: Retrospective cohort. SETTING: University teaching hospitals. PATIENT(S): Women with endometriosis and control women, confirmed with the use of laparoscopy. INTERVENTIONS(S): Diagnostic laparoscopy and blood sample. MAIN OUTCOME MEASURE(S): Next-generation sequencing (NGS) and quantitative real-time PCR (qRT-PCR). RESULT(S): Candidate miRNAs differentially expressed in women with endometriosis compared with control women were identified by means of NGS and selected for qRT-PCR. Plasma samples from another cohort of women with surgically confirmed endometriosis (n = 53) and disease-free control women (n = 53) were checked for hemolysis using spectrophotometry and the ratio of miR-23a and miR-451 by means of qRT-PCR. MicroRNA signatures were quantified by means of qRT-PCR in hemolysis-free plasma samples of case subjects (n = 25) and control subjects (n = 28) with the use of miRcury LNA miRNA. Circulating levels of eight miRNAs (miR-199a-3p, miR-143-3p, miR-340-5p, let-7b-5p, miR-21-5p, miR-17-5p, miR-20a-5p, and miR-103a-3p) were significantly lower in case subjects compared to control subjects. The sensitivity and specificity for individual miRNAs ranged from 0.36 to 1.00 and from 0.43 to 1.00, respectively, but when combined produced sensitivity and specificity of 0.92 and 0.86 with positive (PPV) and (NPV) predictive values of 0.85 and 0.92, respectively. However, combination of five miRNAs (miR-17-5p, miR-20a-5p, miR-199a-3p, miR-143-3p, and let-7b-5p) produced sensitivity and specificity of 0.96 and 0.79 with PPV and NPV of 0.80 and 0.96, respectively. CONCLUSION(S): We conclude that a panel of candidate miRNAs was comparable to laparoscopy in distinguishing between women with endometriosis and control women.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Papari E, Noruzinia M, Kashani L, et al. Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction. Fertil Steril. 2020. PMID: 32482255. doi:10.1016/j.fertnstert.2020.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。